Search research articles
Contact Us
Filters
Showing results (211-220 of 232) with videos related to
Page
of 24
Sort By:
Leukemia
|
October 6, 2019
Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm
Anna B Halpern, Nicholas P Howard, Megan Othus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Haematologica
|
June 27, 2012
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Judith E Karp, Elizabeth Garrett-Mayer, Elihu H Estey, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Prognostic impact of age and MDS-associated mutations in <i>NPM1</i> -mutated AML
Vivian M Liu, Megan Othus, Jasmine Naru, et al.
Blood
|
January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A Goldman, Sean M Devlin, et al.
Biomarker Research
|
August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Era L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Ejhaem
|
December 18, 2024
Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report
Jasmine Naru, Megan Othus, ChenWei Lin, et al.
Blood
|
June 1, 2026
[211At]Astatine-Based Conditioning with a Humanized CD45 Antibody for Autologous Hematopoietic Stem Cell Gene Therapy
Stefan Radtke, George S Laszlo, Kyle Swing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2024
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Leukemia
|
November 7, 2023
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
Guillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 232) with videos related to
Sort By:
Page
of 24
Leukemia
|
October 6, 2019
Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm
Anna B Halpern, Nicholas P Howard, Megan Othus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Haematologica
|
June 27, 2012
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Judith E Karp, Elizabeth Garrett-Mayer, Elihu H Estey, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Prognostic impact of age and MDS-associated mutations in <i>NPM1</i> -mutated AML
Vivian M Liu, Megan Othus, Jasmine Naru, et al.
Blood
|
January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A Goldman, Sean M Devlin, et al.
Biomarker Research
|
August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Era L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Ejhaem
|
December 18, 2024
Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report
Jasmine Naru, Megan Othus, ChenWei Lin, et al.
Blood
|
June 1, 2026
[211At]Astatine-Based Conditioning with a Humanized CD45 Antibody for Autologous Hematopoietic Stem Cell Gene Therapy
Stefan Radtke, George S Laszlo, Kyle Swing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2024
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Leukemia
|
November 7, 2023
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
Guillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, et al.
Page
of 24